S1. Correlation between each of port complication and patient clinical characteristics.
Variables | N | Without | Infection | Rotation | Dehiscence | Obstruction | Liquid | Metastasis | |||||||||||
With | P | With | P | With | P | With | P | With | P | With | P | ||||||||
BMI, body mass index; ECOG PS, Eastern Cooperative Oncology Group performance status; PCI, peritoneal cancer index; Yes, gastrectomy plus with port implantation; No, port implantation only; LS, laparoscopic exploration surgery; Open, port implanted with open surgery; Before, before the optimization of port implantation procedure; After, after the optimization of port implantation procedure. | |||||||||||||||||||
Sex | 0.49 | 0.62 | 0.86 | 0.28 | 0.11 | 0.35 | |||||||||||||
Male | 109 | 89 | 6 | 3 | 3 | 1 | 7 | 0 | |||||||||||
Female | 140 | 103 | 10 | 5 | 4 | 0 | 17 | 1 | |||||||||||
Age (year) | 0.87 | 0.18 | 0.71 | 0.46 | 0.31 | 0.46 | |||||||||||||
<60 | 166 | 124 | 10 | 7 | 5 | 1 | 18 | 1 | |||||||||||
≥60 | 83 | 68 | 6 | 1 | 2 | 0 | 6 | 0 | |||||||||||
BMI (kg/m2) | 0.07 | 0.18 | 0.42 | 0.53 | 0.60 | 0.53 | |||||||||||||
<23 | 174 | 138 | 8 | 4 | 6 | 1 | 16 | 1 | |||||||||||
≥23 | 75 | 54 | 8 | 4 | 1 | 0 | 8 | 0 | |||||||||||
ECOG PS | 0.01 | 0.21 | 0.01 | 0.49 | 0.04 | 0.49 | |||||||||||||
0 | 102 | 91 | 1 | 5 | 0 | 0 | 5 | 0 | |||||||||||
1 | 114 | 79 | 12 | 1 | 4 | 1 | 16 | 1 | |||||||||||
2 | 33 | 22 | 3 | 2 | 3 | 0 | 3 | 0 | |||||||||||
PCI | 0.67 | 0.52 | 0.21 | 0.54 | 0.12 | 0.56 | |||||||||||||
0−10 | 65 | 56 | 3 | 1 | 0 | 0 | 4 | 1 | |||||||||||
11−20 | 71 | 51 | 5 | 2 | 2 | 0 | 11 | 0 | |||||||||||
21−39 | 113 | 85 | 8 | 5 | 5 | 1 | 9 | 0 | |||||||||||
Ascites | 0.72 | 0.73 | 0.64 | 0.76 | 0.43 | 0.76 | |||||||||||||
Present | 229 | 175 | 15 | 7 | 7 | 1 | 23 | 1 | |||||||||||
Absent | 20 | 17 | 1 | 1 | 0 | 0 | 1 | 0 | |||||||||||
Prior chemotherapy | 0.97 | 0.73 | 0.90 | 0.51 | 0.50 | 0.14 | |||||||||||||
Present | 78 | 59 | 5 | 2 | 2 | 0 | 9 | 1 | |||||||||||
Absent | 171 | 133 | 11 | 6 | 5 | 1 | 15 | 0 | |||||||||||
Simultaneous surgery | 0.38 | 0.53 | 0.56 | 0.83 | 0.91 | 0.83 | |||||||||||||
Yes | 10 | 9 | 0 | 0 | 0 | 0 | 1 | 0 | |||||||||||
No | 239 | 183 | 16 | 8 | 7 | 1 | 23 | 1 | |||||||||||
Albumin (g/L) | <0.01 | <0.01 | 0.02 | 0.21 | 0.06 | 0.61 | |||||||||||||
<35 | 68 | 40 | 8 | 6 | 4 | 1 | 9 | 0 | |||||||||||
≥35 | 181 | 152 | 8 | 2 | 3 | 0 | 15 | 1 | |||||||||||
Hemoglobin | 0.07 | 0.53 | 0.24 | 0.33 | 0.50 | 0.33 | |||||||||||||
Anemia | 133 | 98 | 12 | 5 | 2 | 1 | 14 | 1 | |||||||||||
Normal | 116 | 94 | 4 | 3 | 5 | 0 | 10 | 0 | |||||||||||
Glucose | 0.06 | 0.63 | 0.14 | 0.76 | 0.70 | 0.76 | |||||||||||||
Euglycemia | 225 | 175 | 12 | 8 | 5 | 1 | 23 | 1 | |||||||||||
Hyperglycemia | 24 | 17 | 4 | 0 | 2 | 0 | 1 | 0 | |||||||||||
Implantation approach | 0.66 | 0.58 | 0.61 | 0.85 | 0.90 | 0.85 | |||||||||||||
LS | 241 | 185 | 16 | 8 | 7 | 1 | 23 | 1 | |||||||||||
Open | 8 | 7 | 0 | 0 | 0 | 0 | 1 | 0 | |||||||||||
Implantation period | 0.02 | 0.20 | 0.09 | 0.22 | 0.03 | 0.22 | |||||||||||||
Before | 114 | 76 | 11 | 5 | 5 | 1 | 15 | 1 | |||||||||||
After | 135 | 116 | 5 | 3 | 2 | 0 | 9 | 0 | |||||||||||
Implantation group | 0.05 | 0.07 | 0.03 | 0.59 | 0.04 | 0.59 | |||||||||||||
Specialized group | 181 | 149 | 9 | 4 | 3 | 1 | 14 | 1 | |||||||||||
Other groups | 68 | 43 | 7 | 4 | 4 | 0 | 10 | 0 |